Delivery Order SPE2DB24D2010-SPE2DB25FZVD4
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, with a ceiling value of $3,127.39. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of November 27, 2024. The contract was not set aside for any specific business...
This federal contract award is for the procurement of Ozempic, a medication used to treat diabetes, with a ceiling value of $10,074.09. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 21, 2024. The contract does not have a set-aside designation, indicating open competition. This...
This federal contract award is for the delivery of Ozempic, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $6,487.57, has a completion date of December 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award is for the delivery of Ozempic, a medication used to manage diabetes, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $41,357.98, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 11, 2024. The contract is a firm fixed-price arrangement, with no set-aside designation indicated. AmerisourceBergen, a for-profit organization, holds a significant...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 22, 2024, with a ceiling value of $1,084.03 and a completion date of November 25, 2024. This is a delivery order contract, with a firm fixed price pricing type. The contract is not designated with a set-aside...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $7,013.45, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 18, 2024 and was awarded on November 15, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award from the Defense Logistics Agency (DLA) is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The contract, valued at $1,161.08, was awarded to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999.00 through December 2025. This IDC serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Ozempic, a prescription medication for the treatment of Type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $1,281.34 and is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic, a medication used to treat diabetes. The contract has a ceiling value of $10,270.96 and an ultimate completion date of October 30, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...